A detailed history of Ranch Capital Advisors Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ranch Capital Advisors Inc. holds 31,196 shares of BMY stock, worth $1.84 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares
31,196
Previous 5,183 501.89%
Holding current value
$1.84 Million
Previous $215,000 650.7%
% of portfolio
0.77%
Previous 0.11%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $1.03 Million - $1.35 Million
26,013 Added 501.89%
31,196 $1.61 Million
Q2 2024

Aug 13, 2024

BUY
$40.25 - $52.99 $120 - $158
3 Added 0.06%
5,183 $215,000
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $143 - $163
3 Added 0.06%
5,180 $280,000
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $1,260 - $1,504
-26 Reduced 0.5%
5,177 $265,000
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $5,846 - $6,537
-101 Reduced 1.9%
5,203 $301,000
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $1,905 - $2,161
-29 Reduced 0.54%
5,304 $367,000
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $0 - $76
1 Added 0.02%
5,333 $379,000
Q2 2022

Aug 10, 2022

BUY
$72.62 - $79.98 $145 - $159
2 Added 0.04%
5,332 $411,000
Q1 2022

May 12, 2022

BUY
$61.48 - $73.72 $122 - $147
2 Added 0.04%
5,330 $389,000
Q4 2021

Feb 08, 2022

BUY
$53.63 - $62.52 $53 - $62
1 Added 0.02%
5,328 $332,000
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $118 - $138
2 Added 0.04%
5,327 $315,000
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $5,819 - $6,337
-94 Reduced 1.73%
5,325 $355,000
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $4,925 - $5,539
-83 Reduced 1.51%
5,419 $342,000
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $64,553 - $73,150
-1,118 Reduced 16.89%
5,502 $341,000
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $647,695 - $717,731
-11,278 Reduced 63.01%
6,620 $399,000
Q2 2020

Aug 12, 2020

BUY
$54.82 - $64.09 $82,833 - $96,839
1,511 Added 9.22%
17,898 $1.11 Million
Q1 2020

May 12, 2020

BUY
$46.4 - $67.43 $538,657 - $782,794
11,609 Added 242.97%
16,387 $913,000
Q4 2019

Feb 13, 2020

SELL
$49.21 - $64.19 $1,623 - $2,118
-33 Reduced 0.69%
4,778 $307,000
Q3 2019

Nov 18, 2019

BUY
$42.77 - $50.71 $205,766 - $243,965
4,811 New
4,811 $244,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ranch Capital Advisors Inc. Portfolio

Follow Ranch Capital Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ranch Capital Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ranch Capital Advisors Inc. with notifications on news.